Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 271

1.

Prognostic impact of tumor location in stage IV colon cancer: A propensity score analysis in a multicenter study.

Ishihara S, Nishikawa T, Tanaka T, Tanaka J, Kiyomatsu T, Kawai K, Hata K, Nozawa H, Kanazawa T, Kazama S, Yamaguchi H, Sunami E, Kitayama J, Hashiguchi Y, Sugihara K, Watanabe T.

Int J Surg. 2014 Aug 1;12(9):925-930. doi: 10.1016/j.ijsu.2014.07.270. [Epub ahead of print]

PMID:
25091400
[PubMed - as supplied by publisher]
2.

Laparoscopic resection of a gastrointestinal stromal tumor of the lower rectum in a patient with coronary artery disease following long-term neoadjuvant imatinib treatment and anticoagulation therapy.

Nozawa H, Kanazawa T, Tanaka T, Takahashi M, Ishihara S, Sunami E, Kitayama J, Ikemura M, Komuro I, Watanabe T.

World J Surg Oncol. 2014 Jul 15;12(1):211. doi: 10.1186/1477-7819-12-211.

PMID:
25022862
[PubMed - in process]
Free PMC Article
3.

A case of extraperitoneal stoma-associated internal hernia after abdominoperineal resection.

Yokoyama Y, Kawai K, Kazama S, Yoneyama S, Tanaka J, Tanaka T, Kiyomatsu T, Nozawa H, Kanazawa T, Yamaguchi H, Ishihara S, Sunami E, Kitayama J, Watanabe T.

World J Surg Oncol. 2014 May 6;12:141. doi: 10.1186/1477-7819-12-141.

PMID:
24886644
[PubMed - in process]
Free PMC Article
4.

Urethral metastasis from a sigmoid colon carcinoma: a quite rare case report and review of the literature.

Kazama S, Kitayama J, Sunami E, Niimi A, Nomiya A, Homma Y, Watanabe T.

BMC Surg. 2014 May 21;14:31. doi: 10.1186/1471-2482-14-31.

PMID:
24884559
[PubMed - in process]
Free PMC Article
5.

Barium enema and CT volumetry for predicting pathologic response to preoperative chemoradiotherapy in rectal cancer patients.

Murono K, Kawai K, Tsuno NH, Ishihara S, Yamaguchi H, Sunami E, Kitayama J, Watanabe T.

Dis Colon Rectum. 2014 Jun;57(6):715-24. doi: 10.1097/DCR.0000000000000070.

PMID:
24807596
[PubMed - indexed for MEDLINE]
6.

Prognostic Impact of Primary Tumor Resection and Lymph Node Dissection in Stage IV Colorectal Cancer with Unresectable Metastasis: A Propensity Score Analysis in a Multicenter Retrospective Study.

Ishihara S, Hayama T, Yamada H, Nozawa K, Matsuda K, Miyata H, Yoneyama S, Tanaka T, Tanaka J, Kiyomatsu T, Kawai K, Nozawa H, Kanazawa T, Kazama S, Yamaguchi H, Sunami E, Kitayama J, Hashiguchi Y, Sugihara K, Watanabe T.

Ann Surg Oncol. 2014 Sep;21(9):2949-55. doi: 10.1245/s10434-014-3719-1. Epub 2014 Apr 24.

PMID:
24763981
[PubMed - in process]
7.

Nuclear Notch3 expression is associated with tumor recurrence in patients with stage II and III colorectal cancer.

Ozawa T, Kazama S, Akiyoshi T, Murono K, Yoneyama S, Tanaka T, Tanaka J, Kiyomatsu T, Kawai K, Nozawa H, Kanazawa T, Yamaguchi H, Ishihara S, Sunami E, Kitayama J, Morikawa T, Fukayama M, Watanabe T.

Ann Surg Oncol. 2014 Aug;21(8):2650-8. doi: 10.1245/s10434-014-3659-9. Epub 2014 Apr 12.

PMID:
24728738
[PubMed - in process]
8.

Intraperitoneal chemotherapy against peritoneal carcinomatosis: current status and future perspective.

Kitayama J.

Surg Oncol. 2014 Jun;23(2):99-106. doi: 10.1016/j.suronc.2014.03.004. Epub 2014 Mar 27.

PMID:
24721661
[PubMed - in process]
9.

Intravenous and intraperitoneal Paclitaxel with s-1 for refractory pancreatic cancer with malignant ascites: an interim analysis.

Takahara N, Isayama H, Nakai Y, Sasaki T, Ishigami H, Yamashita H, Yamaguchi H, Hamada T, Uchino R, Mizuno S, Miyabayashi K, Mohri D, Kawakubo K, Kogure H, Yamamoto N, Sasahira N, Hirano K, Ijichi H, Tateishi K, Tada M, Kitayama J, Watanabe T, Koike K.

J Gastrointest Cancer. 2014 Sep;45(3):307-11. doi: 10.1007/s12029-014-9603-1.

PMID:
24676891
[PubMed - in process]
10.

Temsirolimus and chloroquine cooperatively exhibit a potent antitumor effect against colorectal cancer cells.

Kaneko M, Nozawa H, Hiyoshi M, Tada N, Murono K, Nirei T, Emoto S, Kishikawa J, Iida Y, Sunami E, Tsuno NH, Kitayama J, Takahashi K, Watanabe T.

J Cancer Res Clin Oncol. 2014 May;140(5):769-81. doi: 10.1007/s00432-014-1628-0. Epub 2014 Mar 12.

PMID:
24619662
[PubMed - indexed for MEDLINE]
11.

Intraperitoneal Paclitaxel is useful as adjuvant chemotherapy for advanced gastric cancer with serosal exposure.

Kitayama J, Ishigami H, Yamaguchi H, Emoto S, Watanabe T.

Case Rep Oncol. 2014 Jan 24;7(1):58-64. doi: 10.1159/000358379. eCollection 2014 Jan.

PMID:
24575018
[PubMed]
Free PMC Article
12.

CD90(+)CD45(-) intraperitoneal mesothelial-like cells inhibit T cell activation by production of arginase I.

Kitayama J, Emoto S, Yamaguchi H, Ishigami H, Yamashita H, Seto Y, Matsuzaki K, Watanabe T.

Cell Immunol. 2014 Mar-Apr;288(1-2):8-14. doi: 10.1016/j.cellimm.2014.01.008. Epub 2014 Feb 1.

PMID:
24556645
[PubMed - indexed for MEDLINE]
13.

Drug development for intraperitoneal chemotherapy against peritoneal carcinomatosis from gastrointestinal cancer.

Emoto S, Sunami E, Yamaguchi H, Ishihara S, Kitayama J, Watanabe T.

Surg Today. 2014 Feb 1. [Epub ahead of print]

PMID:
24482110
[PubMed - as supplied by publisher]
14.

CD90+ mesothelial-like cells in peritoneal fluid promote peritoneal metastasis by forming a tumor permissive microenvironment.

Kitayama J, Emoto S, Yamaguchi H, Ishigami H, Watanabe T.

PLoS One. 2014 Jan 21;9(1):e86516. doi: 10.1371/journal.pone.0086516. eCollection 2014.

PMID:
24466130
[PubMed - in process]
Free PMC Article
15.

Intraperitoneal paclitaxel induces regression of peritoneal metastasis partly by destruction of peripheral microvessels.

Kitayama J, Emoto S, Yamaguchi H, Ishigami H, Watanabe T.

Cancer Chemother Pharmacol. 2014 Mar;73(3):605-12. doi: 10.1007/s00280-014-2393-0. Epub 2014 Jan 25.

PMID:
24464356
[PubMed - indexed for MEDLINE]
16.

The miR-363-GATA6-Lgr5 pathway is critical for colorectal tumourigenesis.

Tsuji S, Kawasaki Y, Furukawa S, Taniue K, Hayashi T, Okuno M, Hiyoshi M, Kitayama J, Akiyama T.

Nat Commun. 2014;5:3150. doi: 10.1038/ncomms4150. Erratum in: Nat Commun. 2014;5:4025.

PMID:
24452072
[PubMed - in process]
17.

[Repeated occlusion of the intraperitoneal access port for intraperitoneal chemotherapy in a patient with gastric cancer with peritoneal dissemination].

Sasaki K, Fujiwara Y, Kishi K, Motoori M, Sugimura K, Miyoshi N, Akita H, Gotoh K, Takahashi H, Marubashi S, Noura S, Ohue M, Yano M, Sakon M, Ishigami H, Kitayama J.

Gan To Kagaku Ryoho. 2013 Nov;40(12):2319-21. Japanese.

PMID:
24394098
[PubMed - indexed for MEDLINE]
18.

Changes in the plasma levels of cytokines/chemokines for predicting the response to chemoradiation therapy in rectal cancer patients.

Tada N, Tsuno NH, Kawai K, Murono K, Nirei T, Ishihara S, Sunami E, Kitayama J, Watanabe T.

Oncol Rep. 2014 Jan;31(1):463-71. doi: 10.3892/or.2013.2857. Epub 2013 Nov 19.

PMID:
24253593
[PubMed - in process]
19.

The miR-1-NOTCH3-Asef pathway is important for colorectal tumor cell migration.

Furukawa S, Kawasaki Y, Miyamoto M, Hiyoshi M, Kitayama J, Akiyama T.

PLoS One. 2013 Nov 11;8(11):e80609. doi: 10.1371/journal.pone.0080609. eCollection 2013.

PMID:
24244701
[PubMed - in process]
Free PMC Article
20.

Flow cytometric quantification of intraperitoneal free tumor cells in patients with peritoneal metastasis.

Kitayama J, Emoto S, Yamaguchi H, Ishigami H, Kamei T, Yamashita H, Seto Y, Matsuzaki K, Watanabe T.

Cytometry B Clin Cytom. 2014 Jan;86(1):56-62. doi: 10.1002/cyto.b.21126. Epub 2013 Sep 30.

PMID:
24115348
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk